BlueOcean NutraSciences Inc.

BlueOcean NutraSciences Inc.

August 05, 2014 13:38 ET

BlueOcean NutraSciences CEO Transition

TORONTO, ONTARIO--(Marketwired - Aug. 5, 2014) - The Board of Directors of BlueOcean NutraSciences (TSX VENTURE:BOC) announce the appointment of Mr. Gavin Bogle as BlueOceans' interim CEO effective immediately, replacing Doug Kemp-Welch who will stay as an Advisor until September 8, 2014. Mr. Bogle will remain a director of BlueOcean. Gavin will lead BlueOcean in the next phase of its development after Doug repositioned the company as a specialty producer of oils for the nutraceutical and pharmaceutical industries.

Gavin has more than 20 years of executive, consulting, and legal experience in the nutraceutical and pharmaceutical industries in both the US and Canada. He has an M.Sc. in microbiology and molecular biology, a law degree and an MBA. Gavin has extensive licensing, intellectual property, and corporate experience that BlueOcean will benefit from.

The Board would like to thank Doug Kemp-Welch for his major contributions as CEO of BlueOcean (formerly called Solutions4CO2) over the last four years and wish him success in the future.

About BlueOcean NutraSciences

BlueOcean is a Canadian company that develops specialty oils using innovative product platforms targeted at the rapidly growing health and Wellness and Animal Feed markets.

BlueOcean is developing three specialty oil products: AstaShrimp, AlgaOmega and AstaTene. BlueOcean owns 50% of the participating and voting rights in 70717 Newfoundland and Labrador Ltd, a joint venture with a major Atlantic Canada shrimp processor that provides the shrimp feedstock for the extraction of AstaShrimp, and 50% of Asta NutraSciences Inc., a company formed to develop natural astaxanthin based health and wellness products for the nutraceutical and animal feed markets. BlueOcean wholly owns its AlgaOmega product line.

Forward Looking Statements

This news release may contain forward-looking statements that are based on BlueOcean's expectations, estimates and projections regarding its business and the economic environment in which it operates. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. Statements speak only as of the date on which they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless otherwise required to do so by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information

  • BlueOcean NutraSciences
    Gavin Bogle
    Interim CEO

    BlueOcean NutraSciences
    Dil Vashi
    Manager Corporate Development
    416-803-9435 extension 104